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SUMMARY.-Albumin distributions and turnover rates have been studied
using 131I labelled tracer material in rabbits with Vx2 carcinoma and rats
bearing SP7 fibrosarcoma in comparison with control animals. Albumin
concentrations were reduced in the tumour bearing animals but plasma volumes
increased as the tumours developed. Relative increases were seen in the extra-
vascular distribution of albumin, due partly to albumin pooling in and around
the tumours and possibly also to general increases in capillary permeability.
In the rats there was a considerable increase in the catabolic rate of albumin
which was not related to urinary protein loss. The tumour bearing rabbits
showed evidence both ofincreased catabolism and ofdecreased synthesis and the
combination of the two effects resulted in a greater lowering of albumin concen-
tration than was seen in the rats. Possible mechanisms for these findings and
their significance in human malignant disease are discussed.
A NUMBER ofalbumin turnover studies have been earried out in cancer patients
(Steinfeld, 1960; Waldman etal., 1963; Wetterfors etal., 1962; JarnumandSchwartz,
1960; Cohn et al., 1966; Sum et al., 1964) to try to elucidate the causes ofthe hypo-
albuminaemia which often accompanies malignant disease (Mider et al., 1950).
External protein leakage, decreased synthesis, increased catabolism and additional
extravascular albumin pools have allbeenreported. Theimpossibility ofobtaining
a well-defined homogeneous group ofsubjects with malignant disease and the diffi-
culty ofdefining a valid grodp of controls for comparative measurements probably
contribute to discrepancies between the various reports.
Studies in tumour bearing animals can avoid these particular problems. Nor-
berg and Greenberg (1951), using mice, and Hradec (1958), using rats, studied the
rate of uptake of labelled amino-acids by plasma proteins in tumour bearing
animals. Babson (1956) and Hradec (1958) measuredthe slope oftheintravascular
retention curve after injecting labelled albumin into rats with Walker carcinomas.
All these studies suggested that plasma protein turnover rates are increased by the
presence oftumours. However,theinterpretation oftheuptakestudiesisuncertain
because ofdifferences in competition for amino-acids from other tissues. The other
studies didnot examinethe turnover kinetics in anydetail nordidtheydifferentiate
between loss of tracer from the circulation by equilibration with extravascular
albumin, and loss by catabolism. In addition Dinh and Brassard (1968) have
shown greatly increased renal protein losses in rats with Walker carcinomas.
The present work was carried out to investigate the turnover and the distribu-
tion of albumin in rabbits implanted with Vx2 carcinoma (experiments A and B)
and in rats bearing SP7 fibrosarcoma (experiment C).E. P. WRAIGHT
METHODS
Twelve male New Zealand White rabbits, initially weighing 3 to 31 kg., were
used inexperiment A and 24 similarrabbits, weighing 22 to 3 kg. initially, in experi-
ment B. Vx2 carcinoma wasimplantedinbothexperimentsbyinjection ofminced
tumour into the right thigh muscle. The SP7 fibrosarcoma used in experiment C
was a relatively non-antigenic tumour (Embleton, 1968) which had been trans-
mitted for 18 generations after arising spontaneously in a highly inbed strain of
Wistar rats. A total of 20 male rats of this strain, initially weighing 250-300 g.,
were used. Tumour was implanted in the flank by trochar and cannula under
ether anaesthesia.
The same general principles were followed in all three experiments. Half the
animals in each group were implanted with tumour. The remainder, consisting
oflitter mates ofthose inthe experimental group, received mockimplantations and
acted as controls. When the tumours were well established, every animal received
an intravenous injection of about 5 ,tCi of 131I albumin from a calibrated syringe.
Albumin, prepared as described below, was labelled using iodine monochloride
(McFarlane, 1964). All animals received 0.01% sodium iodide in the drinking
water throughout the experiment from 24 hours before injection. Blood samples
were taken after 5 minutes, at intervals during the next 24 hours and then daily.
Theplasmawasseparatedandthe activity ofameasuredvolumefoundby counting
in a scintillationwell counter connectedto apulseheight analyser (IDL 6000 series).
All activities were calculated relative to a standard prepared from the injection
solution, thus correcting automatically for radioactive decay and systematic
counting errors and enabling the plasma volume to be calculated from the first
sample by the dilution principle. Each plasma sample activity was expressed as a
fraction of the initial sample and this was corrected for any change in plasma
volume to give the fraction ofthe injected dose retained in the plasma at the time
ofthe sample. (The correction was estimated by linear interpolation between the
initial plasma volume and that measured with another injection of tracer at the
end of the experiment). Albumin concentrations in the samples were measured
in experiment A by a Buiret technique after globulin precipitation with 28%
sodium sulphite and in experiments B and C by cellulose acetate electrophoresis
(Webster, 1965).
The fraction ofinjected dose remaining in the body was measured daily using a
clinical whole body counter. Each animal was counted in turn in a box midway
between two 6 inch x 4 inch scintillation crystals, a standard again being used to
correct fordecay andsystematic errors. The first measurement was made immedi-
ately after injection and this was taken as the 100% value with which subsequent
daily counts were compared. The extravascular fraction of the injected activity
at different times was found by subtracting the intravascular retention from the
whole body retention. A typical example of the results from one of the rabbits
is shown in Fig. 1.
Fractional catabolic rates (F.C.R.) were calculated by the urinary excretion/
plasma activity (U/P) method of Campbell et al. (1956). No correction was made
for the effect of blood sampling which amounted to about 4% of the F.C.R. in
rabbits and 6% in rats. The compartment analysis method of Matthews (1957)
was not valid in the tumour-bearing animals because divergence ofthe logarithmic
plots of whole body and plasma activity retention showed that a steady state
situationdid not exist. Thedivergence couldnotbeexplainedinterms ofretention
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FIG. 1.-Semi-logarithmic plot against time of whole body retention (W), intravascular
retention (P) and extravascular retention (Xe) as fractions ofthe injected dose. Data from
a normal rabbit.
ofactivity in fur because the curves were parallel inthecontrolanimals. TheU/P
method is still valid in theory, even in the non-steady state, ifcatabolism occurs in
metabolic equilibrium with the intravascular pool. However, it gives inflated
values for F.C.R. ifthe clearance of iodide from the body is not much more rapid
than albumin breakdown (Matthews, 1966). In the rabbits results by the U/P
methodagreedverycloselywiththeresultsbymoresophisticatedmethods (Wraight,
1969a). Comparison with the results of Matthew's method in the control rats
gave results that were consistently high by a factor of 1 2. Analogue computer
simulation ofthe non-steady state situation suggested that the results by the U/P
method in the tumour bearing rats were also high by about the same factor.
Corrected values of F.C.R. and catabolic rate are therefore included in Table IV
together with the original U/P values.
In the absence of steady state conditions, synthesis rates could not be deter-
minedfrom catabolicratesdirectly. However, inexperiment Bthetotalexchange-
able albumin was measured at the beginning and the end ofthe experiment and it
was therefore possible from the catabolic rate to estimate the rate of synthesis.
The extravascular/intravascular albumin pool ratio (EV/IV ratio) was calcu-
lated by the equilibrium time method (Campbell et al., 1956). This often involves
considerable error in practice due to the difficulty of determining the exact point
of maximum of the extravascular retention curve. This error was minimized by
fitting the whole body and plasma retention data by multiexponential expressions
derived by a " least squares " computer procedure and differentiating the algebraic
difference to find the exact point of maximum. Fairly good agreement ofresults
with the motre sophisticated method of Matthews (1957) was found in the control
rabbits (Wraight, 1969a) and rats.
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The fractional rate of transfer of albumin out of the circulation was found by
deconvolutional analysis (Vitek et at., 1966; Wraight, 1969a).
Therat albumin used forlabelling was isolated frompooled serum byammonium
sulphate fractionation followed by dialysis. Crystalline rabbit albumin separated
by Cohn fractionation (Koch Light, Ltd) was used in the rabbit experiments. In
experiment B the labelled albumin was screened by injection into another rabbit.
This was bled 48 hours later and the serum separated for injection. The validity
ofthe labelled albumin as a metabolic tracer was checked by the following criteria:
(1) There was no excess excretion ofactivity in the first 48 hours after injection.
(2) There was no change in the plasma rate constant with time in the control
animals.
(3) The mean F.C.R. in control animals was in good agreement with previously
reported values in rabbits (Reeve and Roberts, 1959; Matthews, 1965) and
in rats (Matthews, 1957). In rabbits mean results on four occasions were
025, 021, 026 and 0225 calculated both by the U/P method and by com-
partmental analysis. In rats the mean value by compartmental analysis
was 078.
However, the plasma curves were very steep initially in experiment A andthis
mayhave indicated some contamination of the tracer material with small amounts
of haemoglobin or denatured albumin. The calculated fractional transfer rates
were therefore corrected as previously described (Wraight, 1969a). No such
anomalies were detected using the screened material in experiment B.
Twenty-four hours after the final injection oflabelled albumin in experiment A
the total body activity was measured in three rabbits and, after dissection, the
activity in the tumours was also measured. The animals and tumours were also
weighed. The tumours contained 11.4%, 12-4% and 15.8% of the total body
activity and this represented concentration of activity by factors of 1 80, 2-16 and
2*99 respectively, relative to the mean distribution in the body as a whole.
In experiment C, 24 hour urine collections were made at intervals in two tumour
bearing rats and two controls. Protein concentrations were measured by a Folin
technique after precipitation with trichloracetic acid. Daily urinary protein
excretion was the same in tumour bearing animals as in controls and showed no
change with tumour growth.
RESULTS
The mean values of the various turnover parameters measured in the tumour
bearing and control groups ofanimals in the three experiments are given in Tables
I to IV.
Fig. 2 shows the way the mean albumin concentrations and mean plasma vol-
umes in the tumour bearing animals varied during tumour growth in rabbits,
expressed ineach caserelative tothe corresponding values inthe control animals.
Inexperiment B there was a mean net decrease intotalexchangeable albumin of
1-29 g., in the tumour bearing animals compared with a mean increase of 032 g.,
in the controls (P<0 05). The estimated mean synthesis rates were 0-96 g./day
(0-356 g./kg. body wt/day) in the tumour bearing animals and 1-04 g./day (0-378
g./kg. body wt/day) in the controls. These differences were not statistically
significant.
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DISCUSSION
In all three experiments both the serum albumin coincentration and the intra-
vascular albumin mass were significantly decreased in the tumour bearing animals.
The probable causes of these changes are of interest not only in relation to the
particular tumours studied but also because of the light they throw on possible
mechanisms in human malignant disease.
The effect oftumours on plasma volume
A tendency for plasma volume to be increased in cancer patients is suggested
by a number of studies (Bateman, 1951; Kelly et al., 1952; Berlin et al., 1955;
Peden et al., 1960; Blakeley et al., 1962; Banerjee and Narang, 1967). However,
these findings were not confirmed by Reeve etal. (1968). Peden etal. (1960) showed
that the amount of body fat was a significant factor and that quite high plasma
volumes per unit body weight were found in cases of non malignant cachexia.
The main problem in assessing plasma volume determinations in cancer patients
is to decide what are the expected normal values for the patients in question. A
number ofprediction formulae based on weight and height have been derived from
regression analysis ofdata from normal subjects (Nadler et al., 1962), but these are
not necessarily valid in disease situations. Animal studies offer the advantages
ofserial measurement during tumour growth in addition to ease ofcomparison with
normal controls.
In the rats and rabbits there was a significant increase in plasma volume in the
tumour bearing animals. The change in plasma volume per unit body weight
occurred earlier than the absolute volume increase in experiments B and C and
roughly coincided with the first decreases in weight (see Fig. 2). Thus an early
effect oftumour growth was a diminution in body weight, without a corresponding
reduction in plasma volume. However there was an increase in absolute plasma
volume in addition to an apparent effect due to cachexia. This occurred a little
later in tumour development after other effects such as decreased serum albumin
concentration had occurred.
The mechanism of this effect is obscure. Hormnonal changes secondary to the
tumour growth may be responsible. Alternatively the volume change could be
secondary to the decrease in albumin concentration. Increased plasma volume is
seen after plasmapheresis in man (Andersen and Rossing, 1967) and in rabbits
(Matthews, 1965). Increases have also been reported in a number of clinical
conditions in which serum albumin concentration is decreased such as malnutrition
(Picou and Waterlow, 1962), cirrhosis (Dykes, 1968) and nephrotic syndrome
(Jensen et al., 1967), although other factors may play a part in these cases. In
none of the present studies was there a significant correlation between albumin
concentration andplasma volume, soifa directrelationship didexistit wasobscured
by other factors.
There is also the further possibility that if a tumour can itself cause an increase
in plasma volume, the resulting plasma dilution might be one of the factors con-
tributingtothehypoalbuminaemia ofmalignancy. Thelackofcorrelationbetween
albumin concentration and plasma volume is evidence against this view also.
Albumin distribution ratio
Even at the start of the turnover studies in the rats when the tumours were
quite small the EV/IV ratio was possiby increased (0)05 <P <0 1) and analogue
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FIG. 2.-Changes in plasma volume, body wxeight and albumin concentration during the growth
of Vx2 carcinoma in rabbits, relative to values in control rabbits. There were 6 animals in
eachgroup in experiment A and 12 in each group in experiment B. Each point represents the
mean value in the tumour bearing animals divided by the corresponding value in the control
animals. In the top graph each line has been drawn through the relevant points from both
experimeilts.
simulation suggested that the increase became greater with the growth of the
tumours. In experiment A and following the second injection in experiment B,
the EV/IV ratio was significantlyraised in the tumour bearing rabbits (Tables I and
III). To some extentthis was due to poolingofalbumin in and aroundthetumours
as the measurements suggested that up to 15% ofthe total exchangeable albumin
in the body may be located in a large tumour. Similar pooling at wound sites has
beenshowntocausehypoalbuminaemia inpatientsfollowingoperations (Mouridsen,
1967).
Generalized increases in capillary permeability may also contribute to the
change inthe distributionratio. Thefractional transferratebetweenintravascular
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and extravascular pools was significantly raised in tumour bearing animals in
experiment A, although no such effect was observed in experiment B. Corradi
et al. (1968) have reported increases in overall capillary permeability in cancer
patients. This may be a contributory factor in some cases of oedema associated
with malignant disease. The mechanism ofsuch changes is not clear.
The importance ofsuch aredistribution ofalbumin in loweringthe plasma con-
centration probably depends on the ratio of the F.C.R. to the fractional transfer
rate. The effect is likely to be small in rats where the F.C.R. isrelatively high but
is probably appreciable in rabbits and it could make a significant contribution in
man.
Albumin synthesis and catabolism
Matthews (1966) has shown that the higher the F.C.R., the greater is its over-
estimation by the U/P method. It is therefore probable that even the corrected
results for catabolism are too high in the tumour bearing rats. Nevertheless, it is
certainthatthecatabolicrateisincreasedconsiderablyabovenormalinthepresence
ofthe SP7 fibrosarcoma. However, it seemslikelythatthe decrease inintravascu-
laralbuminduringexperimentCisbalancedtosomeextentbytheincreaseinEV/IV
ratio and that the total exchangeable albumin remains much the same. Thus the
synthesis is probably increased nearly as much as catabolism. There is certainly
no evidence ofany depression ofthe synthetic process. It may be that the reason
why there is only a small decrease in albumin concentration is that increased syn-
thesis is able to compensate almost entirely for the large increase in catabolism.
In this respect the SP7 fibrosarcoma probably differs from the Walker carcinoma,
as Toporek (1969) has shown that blood from rats bearing the Walker tumour
depresses albumin synthesis when used to perfuse normal livers. The cause ofthe
increased catabolism with the SP7 is not related to increased urinary loss as it may
be with the Walker carcinoma.
The F.C.R. was also increased in the tumour bearing rabbits in experiment B
(P<0.01). In apparent contrast, the F.C.R. was decreased in experiment A
althoughthis was not significantstatistically. However, eveninthis casetherewas
evidence ofsome influence on catabolism since inthe tumourbearinganimalsthere
was astrongnegative correlation (r = -0 97,P<0 01) betweenthe F.C.R. andthe
intravascular albumin pool size. A similar correlation was seen in experiment B
(r = -0-82, P<0*01) but not in either group of control rabbits. Two rabbits in
experiment A which died before the end of the experiment both had very low
F.C.R. (0.060 and 0.068). This may represent a late manifestation ofthe tumour
growth. The mean F.C.R. in the other three rabbits in experiment A
(0.209 + 0.023) wasidenticalwiththatofthe controls, inspite oftheloweralbumin
concentration.
In experiment A, the absolute catabolic rate was significantly reduced, even
neglecting the results in the two rabbits with terminal disease. This probably
reflected a considerable reduction in synthesis rate, which appeared to become
more marked asthetumoursgrew. TheestimatedrateofsynthesisinexperimentB
was also decreased, although this was not statistically significant.
It may therefore be concluded that the SP7 fibrosarcoma reduces albumin
concentration by increasing albumin catabolism but the Vx2 carcinoma has an
effect both on synthesis and catabolism. Increased catabolism could result from
changes in hormone levels. Adrenocortical steroids have been shown to increase
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albumin catabolism in patients (Sterling, 1960, and Grossman et al., 1960), dogs
(Takeda, 1964) and rabbits (Rothschild et al., 1958), and increased adrenal activity
has been noted both in tumour bearing animals (Begg, 1958; Kavetsky et al., 1962)
and in cancer patients (Licter and Sirett, 1968; Werk and Sholiton, 1960). Alter-
natively it has been suggested (Busch, 1962) that tumours take up and catabolize
albumin as a source of amino-acids. The rate at which this occurs has not been
measured experimentally but Gullino (1966) has suggested on the basis of blood
flow studies that some tumours derive most oftheir protien from this source. The
effect of this on total catabolic rate will be greater if cell loss from tumours occurs
to the extent suggested by Refsum and Berdal (1967).
Decreased synthesis could in theory be the result of restriction of the amino-
acids available to the liver, either due to competition with the tumour or to dimin-
ished protein intake. However, serum amino-acid concentrations tend to be
raised in tumour bearing animals and cancer patients (Henderson and Le Page,
1959). A specific humoral inhibition of albumin synthesis is suggested by liver
perfusionstudies inrats (Toporek, 1969) in whichthesynthesisratewassignificantly
lowered when livers from normal rats were perfused with blood from rats bearing
Walker carcinomas.
Decreases in albumin concentration can potentially be minimized either by
increased albumin synthesis or by reduced catabolism. Increased syntlhesis is
observed after plasmapheresis in rabbits (Matthews, 1965) and in many cases of
nephrotic syndrome (Jensen et al., 1967). Decreased catabolism occurs in cirrhosis
of the liver (Dykes et al., 1966). When the pathological process affects both syn-
thesis and catabolism, as in experiments A and B, such compensation is much more
difficult and the albumin concentration is depressed to a greater extent than if one
process or the other alone were altered. Conversely a relatively small patlhological
change in both synthesis and catabolism may produce a significant reduction in
albumin concentration. Measurements in nine patients with cancer in whom there
was a marked reduction in serum albumin (Wraight, 1969b) revealed no statistically
significant differences from controls in either synthesis or catabolism. It seems
likely that malignant disease can affect both processes and that the relative import-
ance ofeach effect varies with the type oftumour and its size and degree ofspread in
the body. Both increased catabolism (Sum et al., 1964; Cohn et al., 1966) and
decreased synthesis (Steinfeld, 1960; Waldman et al., 1963) have been reported
previously in studies on patients with malignant disease.
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usedwasprovidedforthe Department ofRadiotherapeutics, Cambridge University,
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